Skip to the page

Data / Form D filings / Medmo, Inc.

Medmo, Inc.: Form D filings

Medmo, Inc., a company in New York, NY, filed 10 Form D notices with the SEC between 2017 and 2025. The latest, on October 14, 2025, reports $14.6 million sold of a $14.6 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
122 GRAND STREET, New York, NY, 10013
Phone
(833) 446-3366
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1724863

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 14, 2025New notice$14,621,048$14,621,04812Oct 6, 2025sec.gov
Feb 18, 2025New notice$5,000,000$4,621,050$378,95011Dec 20, 2024sec.gov
Oct 26, 2023New notice$4,999,982$4,999,98213Oct 11, 2023sec.gov
Aug 10, 2022New notice$4,000,000$1,610,000$2,390,00012Jul 26, 2022sec.gov
Aug 11, 2021New notice$2,700,000$2,700,0003Aug 2, 2021sec.gov
Jan 4, 2021New notice$4,000,000$3,000,000$1,000,0001Dec 22, 2020sec.gov
Sep 18, 2019New notice$1,000,000$70,000$930,0002Sep 4, 2019sec.gov
May 1, 2018New notice$150,000$150,0002Apr 16, 2018sec.gov
Feb 7, 2018New notice$25,000$25,0002Jan 27, 2018sec.gov
Dec 15, 2017New notice$50,000$50,0001Nov 30, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lucas TakahashiExecutive Officer, Director, Promoter
Gadi PoratDirector
Robert EpsteinDirector
Christopher KellyDirector

Other companies in New York that filed recently

Every Form D from the week of Oct 13, 2025 · All recent filings in New York · All recent Other filings

Read from SEC EDGAR. Amount sold is what Medmo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.